- Home
- PRPO vs CLIR Comparison
PRPO vs CLIR Comparison
Compare PRPO & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- CLIR
- Stock Information
- Founded
- PRPO N/A
- CLIR 2008
- Country
- PRPO United States
- CLIR United States
- Employees
- PRPO N/A
- CLIR N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- CLIR Industrial Machinery/Components
- Sector
- PRPO Industrials
- CLIR Industrials
- Exchange
- PRPO Nasdaq
- CLIR Nasdaq
- Market Cap
- PRPO 32.4M
- CLIR 30.7M
- IPO Year
- PRPO N/A
- CLIR 2012
- Fundamental
- Price
- PRPO $20.50
- CLIR $0.84
- Analyst Decision
- PRPO
- CLIR Strong Buy
- Analyst Count
- PRPO 0
- CLIR 1
- Target Price
- PRPO N/A
- CLIR $2.00
- AVG Volume (30 Days)
- PRPO 11.3K
- CLIR 156.6K
- Earning Date
- PRPO 11-17-2025
- CLIR 11-19-2025
- Dividend Yield
- PRPO N/A
- CLIR N/A
- EPS Growth
- PRPO N/A
- CLIR N/A
- EPS
- PRPO N/A
- CLIR N/A
- Revenue
- PRPO $21,242,000.00
- CLIR $2,983,000.00
- Revenue This Year
- PRPO N/A
- CLIR $13.13
- Revenue Next Year
- PRPO N/A
- CLIR $143.88
- P/E Ratio
- PRPO N/A
- CLIR N/A
- Revenue Growth
- PRPO 27.05
- CLIR 19.03
- 52 Week Low
- PRPO $3.90
- CLIR $0.46
- 52 Week High
- PRPO $22.38
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- PRPO 51.49
- CLIR 41.89
- Support Level
- PRPO $19.00
- CLIR $0.83
- Resistance Level
- PRPO $21.00
- CLIR $0.96
- Average True Range (ATR)
- PRPO 1.05
- CLIR 0.07
- MACD
- PRPO -0.16
- CLIR -0.02
- Stochastic Oscillator
- PRPO 27.44
- CLIR 7.21
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.